Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma-Reference-Cited by-同舟云学术

Autoantibodies detected in patients with vitiligo vulgaris but not in those with rhododendrol-induced leukoderma

Published:2019-08 Issue:2 Volume:95 Page:80-83
ISSN:0923-1811
Container-title:Journal of Dermatological Science
language:en
Short-container-title:Journal of Dermatological Science

Author:

Arase Noriko,Tanemura Atsushi,Jin Hui,Nishioka Megumi,Aoyama Yumi,Oiso Naoki,Matsunaga Kayoko,Suzuki Tamio,Nishigori Chikako,Kawamura Tatsuyoshi,Shimizu Tadamichi,Ito Akiko,Fukai Kazuyoshi,Abe Yuko,Yang Lingli,Tsuruta Daisuke,Takeoka Keiko,Iwatani Yoshinori,Hidaka Yoh,Nishida Makoto,Yamauchi-Takihara Keiko,Arase Hisashi,Fujimoto Manabu,Katayama Ichiro

Funder

JSPS KAKENHI

Japan Agency for Medical Research and Development

Japan Health, Labour and Welfare Policy Research Grants

Publisher

Elsevier BV

Subject

Dermatology,Molecular Biology,Biochemistry

Reference10 articles.

1. Guide for medical professionals (i.e., dermatologists) for the management of Rhododenol-induced leukoderma;Nishigori;J. Dermatol.,2015

2. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism;Sasaki;Pigment Cell Melanoma Res.,2014

3. Tyrosinase-catalyzed oxidation of rhododendrol produces 2-methylchromane-6,7-dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity;Ito;Pigment Cell Melanoma Res.,2014

4. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin;Abe;J. Dermatol. Sci.,2016

5. The effect of rhododendrol inhibition of NF-kappaB on melanocytes in the presence of tyrosinase;Arase;J. Dermatol. Sci.,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From mice to men: An assessment of preclinical model systems for the study of vitiligo;Clinical Immunology;2024-05

2. Update on the pathogenesis of vitiligo;Anais Brasileiros de Dermatologia;2022-07

3. Drug-Induced Pigmentary Disorders;Drug Eruptions;2022

4. Rhododendrol‐induced leukoderma update II: Pathophysiology, mechanisms, risk evaluation, and possible mechanism‐based treatments in comparison with vitiligo;The Journal of Dermatology;2021-05-05